Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma Drug in $7.8B Deal
Gilead Sciences and Arcellx have been collaborating on the a number of myeloma cell remedy anito-cel since 2022. This remedy ...
Gilead Sciences and Arcellx have been collaborating on the a number of myeloma cell remedy anito-cel since 2022. This remedy ...
Many predicted increased M&A activity in the digital health space in 2025, and so far they seem to be right. ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.